Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scott

Showing results (291-300 of 355) with videos related to

Pageof 36
Sort By:
Blood Advances|October 24, 2018
High-resolution architecture and partner genes of <i>MYC</i> rearrangements in lymphoma with DLBCL morphologyLauren C Chong, Susana Ben-Neriah, Graham W Slack, et al.
Blood Transfusion = Trasfusione Del Sangue|November 29, 2016
Summary report of the First International Conference on inhibitors in haemophilia ASebastien Lacroix-Desmazes, David W Scott, Jenny Goudemand, et al.
Leukemia|August 16, 2024
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaborationFabian Frontzek, Loïc Renaud, Ulrich Dührsen, et al.
Blood Advances|April 15, 2026
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphomaLaura K Hilton, Sierra Gillis, Faraneh Yahyaei-Moayyed, et al.
Blood|September 22, 2020
Mutational landscape of gray zone lymphomaClémentine Sarkozy, Stacy S Hung, Elizabeth A Chavez, et al.
Blood|February 9, 2026
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin LymphomaCatherine Diefenbach, Opeyemi Jegede, Victoria Wang, et al.
Cancer Discovery|February 2, 2019
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune RecognitionDaisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, et al.
Cell|July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory FateLeandro Venturutti, Matt Teater, Andrew Zhai, et al.
Blood|October 29, 2020
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHCBrett Collinge, Susana Ben-Neriah, Lauren Chong, et al.
Blood|January 9, 2014
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissueDavid W Scott, George W Wright, P Mickey Williams, et al.
Pageof 36

Showing results (291-300 of 355) with videos related to

Sort By:
Pageof 36
Blood Advances|October 24, 2018
High-resolution architecture and partner genes of <i>MYC</i> rearrangements in lymphoma with DLBCL morphologyLauren C Chong, Susana Ben-Neriah, Graham W Slack, et al.
Blood Transfusion = Trasfusione Del Sangue|November 29, 2016
Summary report of the First International Conference on inhibitors in haemophilia ASebastien Lacroix-Desmazes, David W Scott, Jenny Goudemand, et al.
Leukemia|August 16, 2024
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaborationFabian Frontzek, Loïc Renaud, Ulrich Dührsen, et al.
Blood Advances|April 15, 2026
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphomaLaura K Hilton, Sierra Gillis, Faraneh Yahyaei-Moayyed, et al.
Blood|September 22, 2020
Mutational landscape of gray zone lymphomaClémentine Sarkozy, Stacy S Hung, Elizabeth A Chavez, et al.
Blood|February 9, 2026
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin LymphomaCatherine Diefenbach, Opeyemi Jegede, Victoria Wang, et al.
Cancer Discovery|February 2, 2019
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune RecognitionDaisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, et al.
Cell|July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory FateLeandro Venturutti, Matt Teater, Andrew Zhai, et al.
Blood|October 29, 2020
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHCBrett Collinge, Susana Ben-Neriah, Lauren Chong, et al.
Blood|January 9, 2014
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissueDavid W Scott, George W Wright, P Mickey Williams, et al.
Pageof 36